NCT05871008 - Integrated Actionable Aging Assessment for Cancer Patients Pilot | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

August 6, 2024

Study Completion Date

December 31, 2026

Conditions

Breast CancerHodgkin LymphomaKidney CancerLeukemiaLymphoid LeukemiaMultiple MyelomaMyeloid LeukemiaMonocytic LeukemiaProstate CancerBladder Cancer

Interventions

OTHER

Assessment tool IA3-CP with SDoH

Each patient randomly assigned to IA3-CP with SDoH study arm will complete a pre-visit assessment tool including SDoH. Feedback is provided to provider and patient.

OTHER

Assessment tool IA3-CP without SDoH

Each patient randomly assigned to IA3-CP only study arm will complete a pre-visit assessment tool excluding SDoH. Feedback is provided to provider and patient.

Trial Locations (1)

80045

University of Colorado Hospital, Aurora

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER